Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.35 |
| ▸ | CES2 | O00748 | 1/20 | 0.35 |
| ▸ | CES1 | P23141 | 1/20 | 0.35 |
| ▸ | HDAC3 | O15379 | 4/20 | 0.33 |
| ▸ | HDAC1 | Q13547 | 4/20 | 0.33 |
| ▸ | HDAC2 | Q92769 | 4/20 | 0.33 |
| ▸ | HDAC8 | Q9BY41 | 4/20 | 0.33 |
| ▸ | FFAR3 | O14843 | 3/20 | 0.33 |
| ▸ | CTSD | P07339 | 1/20 | 0.33 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.32 |
| ▸ | TSHR | P16473 | 1/20 | 0.32 |
| ▸ | HDAC6 | Q9UBN7 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Trimethylammonium SCHEMBL421126 | 0.91 | TDP1 (0.38) | TDP1CES2CES1HDAC3HDAC1 | |
| Trimethylammonium SCHEMBL28049127 | 0.89 | TDP1 (0.36) | TDP1CES2CES1HDAC3HDAC1 | |
| Trimethylammonium SCHEMBL2435214 | 0.89 | TDP1 (0.36) | TDP1CES2CES1HDAC3HDAC1 | |
| SCHEMBL422556 | 0.89 | — | — | |
| SCHEMBL9619166 | 0.87 | TDP1 (0.35) | TDP1CES2CES1HDAC3HDAC1 | |
| Ammonia Solution, Strong SCHEMBL8445489 | 0.86 | — | — | |
| Methylamine SCHEMBL4377431 | 0.86 | CES2 (0.41) | TDP1CES2CES1HDAC3HDAC1 | |
| SCHEMBL28204586 | 0.86 | — | — | |
| Hydrochloric Acid SCHEMBL6461485 | 0.86 | — | — | |
| Water SCHEMBL28252944 | 0.86 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 22 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1825884-B1 | Brightening and/or colouring agent with reduced potential for irritation | HENKEL AG & CO KGAA (DE) | 2017-08-16 | — | — | EP | claimed |
| EP-1813260-B1 | Bleaching and/or colouring agent with reduced potential for irritation | HENKEL AG & CO KGAA (DE) | 2017-05-31 | — | — | EP | claimed |
| WO-2005054548-A2 | METHODS, COMPOSITIONS, AND KITS FOR PROTEIN CRYSTALLIZATION | INVITROGEN CORPORATION (US) | 2005-06-16 | — | — | WO | claimed |
| US-20160199282-A1 | PERFORMANCE-ENHANCED HAIR TREATMENT COMPOSITION | HENKEL AG & CO. KGAA (DE) | 2016-07-14 | — | — | US | disclosed |
| WO-2015062596-A1 | HAIR TREATMENT AGENT CONTAINING L-CARNITINE OR AN L-CARNITINE DERIVATIVE AND AN OLIGOPEPTIDE CONTAINING THE SEQUENCE GLU-GLU-GLU | HENKEL AG & CO. KGAA (DE) | 2015-05-07 | — | — | WO | disclosed |
| US-20140271520-A1 | NON-WEIGHING HAIR PREPARATIONS | HENKEL AG & CO., KGAA (DE) | 2014-09-18 | — | — | US | disclosed |
| US-8802068-B2 | Non-weighing hair preparations | HENKEL AG & CO. KGAA (DE) | 2014-08-12 | — | — | US | disclosed |
| US-20130319863-A1 | METHODS, COMPOSITIONS, AND KITS FOR PROTEIN CRYSTALLIZATION | Life Technologies Corporation (US) | 2013-12-05 | — | — | US | disclosed |
| US-8444838-B2 | Methods, compositions, and kits for protein crystallization | Life Technologies Corporation (US) | 2013-05-21 | — | — | US | disclosed |
| US-20120251473-A1 | NON-WEIGHING HAIR PREPARATIONS | HENKEL AG & CO. KGAA (DE) | 2012-10-04 | — | — | US | disclosed |
| US-20120201773-A1 | UNENCUMBERING HAIR TREATMENT PRODUCT | HENKEL AG & CO. KGAA (DE) | 2012-08-09 | — | — | US | disclosed |
| US-7850835-B2 | Solution phase electrophoresis device, components, and methods | Life Technologies Corporation (US) | 2010-12-14 | — | — | US | disclosed |
| US-20100215604-A1 | Cosmetic Compositions with Chitosan and Silicone Elastomers | HENKEL AG & CO. KGAA (DE) | 2010-08-26 | — | — | US | disclosed |
| US-20090304620-A1 | HAIR TREATMENT PRODUCTS COMPRISING POLYMERS | HENKEL AG & CO. KGAA (DE) | 2009-12-10 | — | — | US | disclosed |
| US-7622028-B2 | Solution phase electrophoresis device, components, and methods | Life Technologies Corporation (US) | 2009-11-24 | — | — | US | disclosed |
| US-20090218547-A1 | METHODS, COMPOSITIONS, AND KITS FOR PROTEIN CRYSTALLIZATION | Life Technologies Corporation (US) | 2009-09-03 | — | — | US | disclosed |
| CN-101394830-A | Cosmetic agents comprising purine and/or purine derivatives I | HENKEL KGAA (DE) | 2009-03-25 | — | — | CN | disclosed |
| US-20050202405-A1 | Methods, compositions, and kits for protein crystallization | Life Technologies Corporation | 2005-09-15 | — | — | US | disclosed |
| US-20050023141-A1 | Solution phase electrophoresis device, components, and methods | Life Technologies Corporation | 2005-02-03 | — | — | US | disclosed |
| US-20050006239-A1 | Solution phase electrophoresis device, components, and methods | Life Technologies Corporation | 2005-01-13 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (8 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090304620-A1 | HAIR TREATMENT PRODUCTS COMPRISING POLYMERS | ASS1, SRM, COL1A1 | TDP1 3165/4885CES2 1684/4885CES1 3064/4885 |
| US-20100215604-A1 | Cosmetic Compositions with Chitosan and Silicone Elastomers | HDAC10, HDAC1, HDAC3 | TDP1 3339/4885CES2 718/4885CES1 2736/4885 |
| US-20120201773-A1 | UNENCUMBERING HAIR TREATMENT PRODUCT | POLR1C, SPTAN1, SMURF1 | TDP1 4173/4885CES2 2489/4885CES1 4118/4885 |
| US-20120251473-A1 | NON-WEIGHING HAIR PREPARATIONS | KRT18, KRTCAP2, PSMB10 | TDP1 3411/4885CES2 2910/4885CES1 3537/4885 |
| US-20130319863-A1 | METHODS, COMPOSITIONS, AND KITS FOR PROTEIN CRYSTALLIZATION | CHLSN, CPN1, CRYAA | TDP1 2747/4885CES2 2657/4885CES1 1462/4885 |
| US-20160199282-A1 | PERFORMANCE-ENHANCED HAIR TREATMENT COMPOSITION | KRT18, YWHAZ, PHYKPL | TDP1 3582/4885CES2 3476/4885CES1 2616/4885 |
| US-20140271520-A1 | NON-WEIGHING HAIR PREPARATIONS | KRT18, KRTCAP2, PSMB10 | TDP1 3411/4885CES2 2910/4885CES1 3537/4885 |
| US-20050006239-A1 | Solution phase electrophoresis device, components, and methods | PROC, RAB5IF, SPECC1L | TDP1 715/4885CES2 1818/4885CES1 2125/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.